[Outcome and outlook of living donor kidney transplantation activity in France].

Agence de la biomédecine, direction médicale et scientifique-1, avenue du Stade-de-France-Saint-Denis, 93212 La-Plaine cedex, France.
Néphrologie & Thérapeutique (Impact Factor: 0.5). 02/2011; 7(7):535-43. DOI: 10.1016/j.nephro.2011.01.001
Source: PubMed

ABSTRACT In France, the bioethic law of 2004 authorized the extension of the living donor (LD) pool to members of the extended family and any person justifying of a 2 year-long relationship. The number of living donor kidney transplantation (LDKT) increased until reaching a maximum of 246 grafts in 2006 (9% of total activity). Two years later, in 2008, LKG activity slowed down to 7.6% of the total activity (222 grafts).
We analyzed all LDKT carried out in France since 2000 according to various indicators. In addition, a questionnaire was sent to renal transplant teams in order to identify potential causes for the decrease in LKG observed in France.
From 2000 to 2006, over 1400 LDKT were performed in France. However, donor to recipient relations show that the large increase observed in 2006 was not linked to the extension of the LD pool. LDKT activity then started decreasing as soon as 2007. The questionnaire was sent back by 40/44 (91%) renal transplant teams. Their answers led to the identification of potential constrain impacting LDKT activity in France. Among these obstacles: workload and time-consuming to prepare the transplantation and the donor, ethical constrains and lack of appropriate communication and information delivered to the professionals.
The important increase in LKG activity in 2006 is not clearly understood. However, several approaches to develop the activity in the next years have been identified.

  • [Show abstract] [Hide abstract]
    ABSTRACT: France has reached a pretty good level of activity, comparable to southern European countries: in 2011, 4945 transplantations (TX) have been performed among them, 2976 (60%) kidney TX, 1164 (24%) liver TX, 398 (8%) heart TX and 312 (6.3%) lung TX. However, the progression has slowed down since 2008 like in many countries. The potential of donors is mainly represented by the donor after brain-death (DBD) (90%), living donor (LD) for kidneys transplantation participates for only 10% of the overall kidney TX, and donor after cardiac death (DCD) activity, just started in 2006, for 2.2%. Current challenges to maximize the existing activity of DBD rely upon the implementation of program aimed to monitor deceased organ donation potential, a comprehensive approach of the regional disparities covering the steps of the detection of the potential donor, the rate of organ procurement and the refusal rate to organ donation. The profile of the donors has changed due to substantial epidemiologic shifts and a growing shortage of organs. The resource of expanded criteria donor (ECD) is widely used, mainly defined by a criteria of age. This policy is acceptable and successful under specific allocation scheme based on a donor-recipient matching. Before the TX needs of the population have been adequately met, the opportunities for improvement should be the development of DCD and LD activities, in addition to DBD activity. The extension to the DCD of the 3rd category of Maastricht is currently devised as a possible option for the future. The development of perfusion machine, available for kidney preservation and soon for the other organs is a new technical challenge that might increase the donor pool to previously discarded grafts. This superior and cost-effective method evaluated for ECD kidney preservation has also a potential of resuscitation and prediction of post-transplant outcome. To give a new launch to the TX activity as it was done in 2000, the Agency together with the professionals, has elaborated a "new action plan" for the next few years, which has been acted on April 2012 by the Minister of health.
    La Presse Médicale 07/2012; · 0.87 Impact Factor
  • Néphrologie & Thérapeutique 10/2013; · 0.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Haute Autorité de santé, in association with the Agence de la biomédecine, realizes, at the request of the Caisse nationale d'assurance maladie des travailleurs salariés and the Direction générale de l'offre de soins, a medical economic evaluation on treatment's alternative of terminal chronic renal insufficiency. To answer at this request, a multiannual working program was set up. A first part of this work concerned specifically the development of the kidney transplant. Indeed, the kidney transplant occupies a particular place among the various modalities of treatment of the terminal chronic renal insufficiency because it is at the same time the most effective on a medical plan and the least expensive, thus the most efficient. However, its development is constraint by the lack of the transplants and the number of patients registered on the national list of wait increases every year. The objective of this article is to present the method of work as well as the main identified axes of development.
    Néphrologie & Thérapeutique 04/2014; · 0.50 Impact Factor